Newsletter of MEDICA | View in browser | Deutsch | Print
Header of MEDICA Newsletter

Artificial intelligence in skin cancer diagnostics

Dear Sir or Madam,

Some consider it an attractive feature, others perceive it as a stain: birthmarks. But no matter if you love or hate them, as soon as moles show suspicious changes, they are usually removed. A new method promises to be so precise in the diagnostics of black skin cancer that birthmarks will not have to be removed in vain anymore. Learn more in our current interview.

I wish you a happy week,

Julia Unverzagt
Editorial team MEDICA-tradefair.com
image: 12 - 15 November 2018, MEDICA - World Forum for Medicine in Düsseldorf

Table of Contents

Topic of the Month: Latin America's medical market
Interview: skin cancer diagnostics
Newsletter Service
RSS Service
Newsletter Archive

Between austerity measures and growth pressure - Latin America's medical market

Topic of the Month

Image: golden globe showing the South American continent; Copyright: panthermedia.net/threeart
A region whose states make up the world's third largest economy and which has few linguistic differences - Latin America is an attractive market for foreign companies at first glance. This also applies to the medical market. However, various factors are contributing to the fact that this market is growing only slowly in most countries.
Read more in our Topic of the Month:
Between austerity measures and growth pressure - Latin America's medical market
South America – Medical technology in Brazil and Colombia

Research & Technology

Attention deficit disorders stem from impaired brain coordination?

Researchers from Case Western Reserve University School of Medicine and colleagues have discovered how two brain regions work together to maintain attention, and how discordance between the regions could lead to attention deficit disorders, including schizophrenia, bipolar disorder, and major depression.
read more
To top

Research & Technology

Efficient genetic modification of immune cells

A new method enables genes in living T-cells in mice to be modified quickly and efficiently. It makes use of plasmids, a tried-and-tested method of genetic engineering. Researchers from the Department of Biomedicine at the University of Basel and University Hospital Basel reported these findings in the Journal of Immunology.
read more
To top

Research & Technology

TrueBrainConnect: predicting brain disorders

Hosted by Charité – Universitätsmedizin Berlin, the TrueBrainConnect project aims to systematically study connections between different areas of the brain, and hopes to draw conclusions regarding potential disease patterns.
read more
To top

A startup makes melanin glow: skin cancer diagnostics with Magnosco

Interview

Image: DermaFC developed by Magnosco; Copyright: Magnosco
When a skin lesion is suspected to exhibit malignant changes, it is usually promptly removed. However, not all cases require an excision of the affected tissue. The startup company Magnosco has developed a procedure that uses a laser to support the diagnosis and early detection of malignant melanoma.
Read the interview here:
A startup makes melanin glow: skin cancer diagnostics with Magnosco
All interviews at MEDICA-tradefair.com
To top

Newsletter Service

You like our newsletter? Then please recommend us: Forward this newsletter or the link www.MEDICA.de/news_login_2 to your friends and colleagues.

If you have difficulties with your order, please write an e-mail to redaktion@medica.de.
To top
Legal disclaimer

Messe Düsseldorf GmbH
Messeplatz, Stockumer Kirchstr. 61
40474 Düsseldorf, Germany

Phone: +49 (0)211 / 4560-01
Fax: +49 (0)211 / 4560-668
www.messe-duesseldorf.de
info@messe-duesseldorf.de

County Court Düsseldorf HRB 63

Board of Managing Directors: Werner M. Dornscheidt (Chairman), Hans Werner Reinhard, Joachim Schäfer, Bernhard Stempfle

Chairman of Supervisory Board: Mayor Thomas Geisel

Facebook Twitter LinkedIn YouTube

Should you no longer wish to receive our newsletter, please click here.